Home/Filings/4/0001437749-24-000899
4//SEC Filing

WEISS MICHAEL S 4

Accession 0001437749-24-000899

CIK 0001001316other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 6:32 PM ET

Size

5.1 KB

Accession

0001437749-24-000899

Insider Transaction Report

Form 4
Period: 2024-01-05
WEISS MICHAEL S
DirectorCEO
Transactions
  • Award

    Common Stock

    2024-01-06+1,001,90813,074,929 total
Footnotes (2)
  • [F1]Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date.
  • [F2]Includes shares of restricted Common Stock, which vest over various time periods.

Issuer

TG THERAPEUTICS, INC.

CIK 0001001316

Entity typeother

Related Parties

1
  • filerCIK 0001038977

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:32 PM ET
Size
5.1 KB